Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel betacoronavirus, caused a pandemic leading to a standstill of nearly all global activities. There are some controversies on the production of specific immunoglobulin M (IgM) and IgG antibodies after the infection with SARS-CoV-2. This paper seeks to elaborate on the potential application of IgM and IgG antibodies and the viral antigens for the diagnosis and the course of the disease as well as the recurrence of positive nucleic acid tests after discharge.
Keywords: IgG; IgM; SARS-CoV-2; antibody; coronavirus; diagnosis.
All Keywords
【저자키워드】 SARS-CoV-2, IgG, IgM, coronavirus, antibody, diagnosis., 【초록키워드】 pandemic, Diagnosis, discharge, IgG antibody, Immunoglobulin, nucleic acid test, IgM and IgG, Viral antigen, acute respiratory syndrome, novel Betacoronavirus, activities, positive, Course, caused, the disease, infection with SARS-CoV-2, 【제목키워드】 serological test, Potential,
【저자키워드】 SARS-CoV-2, IgG, IgM, coronavirus, antibody, diagnosis., 【초록키워드】 pandemic, Diagnosis, discharge, IgG antibody, Immunoglobulin, nucleic acid test, IgM and IgG, Viral antigen, acute respiratory syndrome, novel Betacoronavirus, activities, positive, Course, caused, the disease, infection with SARS-CoV-2, 【제목키워드】 serological test, Potential,
{{{ 추상적인 }}}
중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2)는 신종 베타코로나바이러스로, 거의 모든 글로벌 활동을 중단시키는 대유행을 일으켰습니다. SARS-CoV-2 감염 후 특정 면역글로불린 M(IgM) 및 IgG 항체의 생성에 대해 일부 논란이 있습니다. 이 논문은 퇴원 후 양성 핵산 검사의 재발뿐만 아니라 질병의 진단 및 경과에 대한 IgM 및 IgG 항체 및 바이러스 항원의 잠재적인 적용에 대해 자세히 설명하고자 합니다.
{{ 키워드: }} IgG; IgM; 사스 코로나바이러스 2; 항독소; 코로나바이러스; 진단.